Market Research Logo

Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical, Nano medicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits Market), and by Region - Global Industry Insights, and Forecast to 2025

Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical, Nano medicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits Market), and by Region - Global Industry Insights, and Forecast to 2025

Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment archetypes and rapid technological innovation such as cell therapy and regenerative medicines.
Market Dynamics
Launches and approvals of novel biopharmaceutical and biomedicine products is expected to drastically drive growth of global biopharmaceutical and biomedicine market in the near future. For instance, in 2016, Sanofi S.A. received U.S. FDA approval for its Adlyxin ((lixisenatide) injection. Adlyxin is indicated to improve blood sugar levels among adults suffering from type 2 diabetes. In 2016, Johnson & Johnson received U.S. FDA approval for its Stelara (Ustekinumab), indicated for the treatment of adults suffering from moderately to severely active crohn’s disease. In 2016, CSL Behring received U.S. FDA approval for its IDELVION, Coagulation Factor IX (Recombinant), Albumin Fusion Protein. IDELVION is indicated for the treatment of Hemophilia B among children and adults. In 2017, Nanostring Technologies, Inc. launched nCounter platform advances as well as new panels expanding the company’s presence in immuno-oncology and 3D biology research. In 2015, Celltrion Healthcare Co., Ltd. launched its Remsima (infliximab), a biosimilar monoclonal antibody (mAb) in Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden, and the UK. Furthermore, increasing collaborations and acquisitions by major key players in market is also expected to create lucrative environment for growth of market. For instance, in 2016, Biocon Ltd., wholly owned subsidiary of Biocon SA, collaborated with Laboratorios PiSA S.A. de C.V—a Mexico-based company—for the co-development and commercialization of generic recombinant human insulin (rh-insulin) in the U.S. market. In 2016, AbbVie Inc. acquired all rights from Boehringer Ingelheim (BI) for Risankizumab (BI 655066). Risankizumab is an anti-IL-23 monoclonal biologic antibody for psoriasis. Company is also evaluating the product for other indications such as Crohn’s disease, asthma, and psoriatic arthritis. Currently, it is in clinical phase 3.
Key features of the study:

  • This report provides in-depth analysis of biopharmaceutical and biomedicine market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global biopharmaceutical and biomedicine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Amgen Inc., F. Hoffmann-La Roche AG, Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol - Myers Squibb, NanoString Technologies, Inc., Qiagen N.V., Celgene Corporation, and Affimed N.V.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biopharmaceutical and biomedicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biopharmaceutical and biomedicine market
Detailed Segmentation:
  • Global Biopharmaceutical and Biomedicine Market, By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits Market
  • Global Biopharmaceutical and Biomedicine Market, By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • Global Biopharmaceutical and Biomedicine Market, By Geography:
  • North America
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits Market
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits Market
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits Market
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type :
  • Biopharmaceutical
  • Monoclonal Antibodies Market
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Blood Factors
  • Fusion Protein
  • Others
  • By Application:
  • Therapeutics
  • Diagnostics
  • Research and Development
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Amgen Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments
  • Key Strategies
  • F. Hoffmann-La Roche AG
  • Novartis AG
  • Johnson & Johnson
  • Pfizer, Inc.
  • Sanofi S.A.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Novo Nordisk A/S
  • Bristol - Myers Squibb
  • NanoString Technologies, Inc.
  • Qiagen N.V.
  • Celgene Corporation
  • Affimed N.V.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
PEST Analysis
Pipeline Analysis
Product Approval
Product Launch
Collaboration-Acquisition
Porter’s Five Forces Analysis
4. Global Biopharmaceutical and Biomedicine Market, By Product Type, 2015–2025 (US$ Bn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Biopharmaceutical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Segment Trends
Monoclonal Antibodies Market
Vaccines
Recombinant Human Insulin
Human Growth Hormone
Erythropoietin
Interferon
Colony Stimulating Factor
Blood Factors
Fusion Protein
Others
Nanomedicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Cell & Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Bioinformatics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Molecular Enzymes & Kits Market
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
5. Global Biopharmaceutical and Biomedicine Market, By Application, 2015–2025 (US$ Bn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Therapeutics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
Research and Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Bn)
6. Global Biopharmaceutical and Biomedicine Market, By Region, 2015–2025 (US$ Bn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2016–2025
North America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Product Type, 2015–2025 (US$ Bn)
Market Size and Forecast, By Application, 2015–2025 (US$ Bn)
Market Size and Forecast, By Country, 2015–2025 (US$ Bn)
GCC
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Amgen Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novo Nordisk A/S
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol - Myers Squibb
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
NanoString Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Qiagen N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Celgene Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Affimed N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 45 market data tables and 42 figures on “Biopharmaceutical and Biomedicine Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report